林裕誠 (Yu-Cheng Lin, MD, PhD)   掛號

學歷:

• 國立台灣大學醫學院醫學系學士
• 國立台灣大學臨床醫學研究所醫學博士

現職:

• 臺北榮民總醫院 兒童醫學部 主治醫師
• 臺北榮民總醫院 兒童胃腸科 科主任
• 台灣小兒消化醫學會理事
• 中華民國肥胖研究學會理事
• 兒童肝膽疾病防治基金會董事
• 亞太APPSPGHAN科學委員會委員
• 台灣兒科醫學會研究委員會委員
• 台灣兒科醫學會兒科消化學委員會委員

經歷:

• 亞東紀念醫院小兒部 主治醫師
• 亞東紀念醫院醫療事務處 處主任
• 亞東紀念醫院小兒急診科 科主任
• 亞東紀念醫院共同研究室 科主任
• 科技部生科司婦幼醫學學門 複審委員

醫療專長:

• 兒童青少年肥胖症、脂肪肝
• 兒童青少年腸胃道疾病：嘔吐、腹瀉、腹痛、便秘、出血等
• 幼兒生長遲緩、嬰幼兒營養諮詢
• 兒童青少年肝膽疾病防治
• 腹部超音波、胃鏡、大腸鏡、肝纖維化掃描Fibroscan

證照:

• 兒科專科醫師
• 兒科消化學次專科醫師
• 肥胖症專科醫師
• 青少年醫學次專科醫師
• 消化系內視鏡專科醫師

得獎事蹟:

• 2009: Young Investigator Award, the 11th Congress of the Asian Pan-Pacific Society of Pediatric Gastroenterology, Hepatology and Nutrition (APPSPGHAN), Seoul, Korea
• 2014: The 10th Pediatric Research Association Excellent Abstract Award
• 2020:第21屆國家醫療品質獎 -智慧醫療類 -智慧解決方案組 『 標章 』
• 2021: Poster of Distinction Award, 2021 The Taiwan Digestive Disease Week (TDDW)

著作目錄：兒童肥胖及脂肪肝研究相關

1. Yu-Cheng Lin, Chang PF, Hu FC, Chang MH, Ni YH. Variants in the UGT1A1 gene and the risk of pediatric non-alcoholic fatty liver disease. Pediatrics. 2009:124(6):e1221-7.
2. Yu-Cheng Lin, Chang PF, Yeh SJ, Liu K, Chen HC. Risk factors associated with liver steatosis in obese children and adolescents. Pediatrics and Neonatology. 2010;51(3):149−54.
3. Yu-Cheng Lin, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH. A common variant in the PNPLA3 gene is a risk factor for nonalcoholic fatty liver disease in obese Taiwanese children. Journal of Pediatrics. 2011;158(5):740-4.
4. Yu-Cheng Lin, Chang PF, Chang MH, Ni YH. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children. American Journal of Clinical Nutrition. 2013;97(2):326-31.
5. Yu-Cheng Lin, Chang PF, Chang MH, Ni YH. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. American Journal of Clinical Nutrition. 2014;99(4):869-74.
6. Chang PF, Yu-Cheng Lin, Liu K, Yeh SJ, Ni YH. Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease. International Journal of Obesity. 2015;39(8):1236-40.
7. Yu-Cheng Lin, Chang PF, Lin HF, Liu K, Chang MH, and Ni YH. Variants in the autophagy related gene IRGM confer susceptibility to nonalcoholic fatty liver disease by modulating lipophagy. Journal of Hepatology. 2016;65(6):1209-1216.
8. Yu-Cheng Lin, Ni YH. Reply to: “Title: The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese children”. Journal of Hepatology. 2017;67(3):655-656.
9. Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Yu-Cheng Lin, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment. Journal of Gastroenterology and Hepatology. 2018;33(1):70-85.
10. Chitturi S, Wong VW, Chan WK, Wong GL, Wong SK, Sollano J, Ni YH, Liu CJ, Yu-Cheng Lin, Lesmana LA, Kim SU, Hashimoto E, Hamaguchi M, Goh KL, Fan J, Duseja A, Dan YY, Chawla Y, Farrell G, Chan HL. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2: Management and special groups. Journal of Gastroenterology and Hepatology. 2018;33(1):86-98.
11. Yu-Cheng Lin, Pi-Feng Chang, Mei-Hwei Chang and Yen-Hsuan Ni. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children. Liver International. 2018;38(7):1300-1307.
12. Hong-Hsing Liu, Yu-Cheng Lin, Chen-Shuan Chung, Kevin Liu, Ya-Hui Chang, Chung-Hsiang Yang, Yun Chen, Yen-Hsuan Ni and Pi-Feng Chang*. Integrated counts of carbohydrate-active protein domains as metabolic readouts to distinguish probiotic biology and human fecal metagenomes. Scientific Reports. 2019;9(1):16836.
13. May-Jen Huang, Yu-Cheng Lin, Kevin Liu, Pi-Feng Chang, Ching-Shan Huang. Effects of variation status and enzyme activity for UDP-glucuronosyltransferase 1A1 gene on neonatal hyperbilirubinemia. Pediatrics and Neonatology. 2020;61(5):506-512.
14. Yu-Cheng Lin, CC Wu, YH Ni. New Perspectives on Genetic prediction for pediatric metabolic associated fatty liver disease. Frontiers in Pediatrics. 2020;8:603654.
15. Yu-Cheng Lin, PF Chang, K Liu, MH Chang and YH Ni. Predictors for incidence and remission of nonalcoholic fatty liver disease in obese children and adolescents. Journal of the Formosan Medical Association. 2022;121:36-42.
16. Yu-Cheng Lin, Lin HF, Wu CC, Chen CL, Ni YH. Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity. Journal of Gastroenterology. 2022;57:913-925.
17. Chen CL, Yu-Cheng Lin. Autophagy dysregulation in metabolic associated fatty liver disease: a new therapeutic target. International Journal of Molecular Sciences. 2022;23(17):10055.
18. Yu-Cheng Lin, Chang PF, Ni YH. Updated upper limits of normal serum alanine aminotransferase levels for screening metabolic dysfunction-associated fatty liver disease in obese children. Journal of the Formosan Medical Association. 2022,121, 2548-2555.
19. Pei-Ching Liu, Yu-Cheng Lin, Bih-Shya Gau, Heng-Hsin Tung, Sophia H. Hu, Chi-Wen Chen. Association between lifestyle-related, psychosocial factors and obesity among female adolescents in Taiwan. Journal of Pediatric Nursing. 2023;68:e58-e68.
20. Po-Sheng Chang, Pi-Feng Chang, Yu-Cheng Lin. Usefulness of the triglyceride glucose index to predict nonalcoholic fatty liver disease in children with obesity. Journal of Pediatrics. 2023;255:260-261.